When did Progyny report Q4 2025 earnings?

Progyny (PGNY) reported Q4 2025 earnings on February 26, 2026 after market close.

What were Progyny's Q4 2025 revenue and EPS?

Progyny reported revenue of $318.4M and eps of $0.15 for Q4 2025.

Did Progyny beat estimates in Q4 2025?

Revenue beat the consensus estimate of $307.4M by $11.0M. EPS beat the consensus estimate of $0.15 by $0.00.

How did Progyny's Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 6.7% from $298.4M a year earlier and eps declined 64.3% from $0.42.

Where can I find Progyny's Q4 2025 SEC filings?

You can read the 8-K earnings release (0001551306-26-000012) and the 10-K periodic report (0001551306-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.

Progyny PGNY Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$318.4MBeat by $11.0M

EPS$0.15Beat by $0.00

Revenue estimate$307.4M

EPS estimate$0.15

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$348.6M

EPS estimate$0.34

Financials

Q4 2025

Income statement

See full

Revenue$318.4M+6.7%

Gross profit$76.9M+21.2%

Operating income$15.2M-3.6%

Net income$12.5M+18.5%

EPS (diluted)$0.14+16.7%

Balance sheet

See full

Cash & equivalents$112.2M-30.9%

Total debt$27.7M+43.9%

Total equity$516.0M+22.3%

Total assets$742.4M+22.3%

Cash flow

See full

Operating cash flow$54.2M+3.9%

CapEx$5.6M+196%

Free cash flow$48.6M-3.3%

Valuation & ratios

Valuation

as of 12/31/25

See full

Market cap$2.21B+50.7%

Enterprise value$2.13B+60.6%

P/E37.8×+10.8×

P/S1.7×+0.5×

Profitability

See full

Gross margin23.6%+1.9pp

Operating margin6.6%+0.8pp

Net margin4.5%-0.1pp

FCF margin14.9%0.0pp

Returns & leverage

See full

Return on equity12.5%+1.3pp

Debt / equity0.1×0.0×

Current ratio2.7×-0.1×

Segments

By product

See full

Fertility benefits services revenue$208.6M+11.3%

Pharmacy benefits services revenue$109.8M-1.1%

By segment

See full

Reportable segment$318.4M+6.7%

Versus estimates

Revenue

Q1 2026$328.5MBeat by $2.0M

Q4 2025$318.4MBeat by $11.0M

Q3 2025$313.3MMiss by $913.8K Q2 2025$332.9MBeat by $33.6M Q1 2025$324.0MBeat by $16.2M Q4 2024$298.4MBeat by $21.1M

Diluted EPS

Q1 2026$0.29Beat by $0.03

Q4 2025$0.15Beat by $0.00

Q3 2025$0.45Beat by $0.06 Q2 2025$0.48Beat by $0.04 Q1 2025$0.48Beat by $0.03 Q4 2024$0.42Beat by $0.05

Ask the moment Progyny reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Progyny report Q4 2025 earnings?: Progyny (PGNY) reported Q4 2025 earnings on February 26, 2026 after market close.
What were Progyny's Q4 2025 revenue and EPS?: Progyny reported revenue of $318.4M and eps of $0.15 for Q4 2025.
Did Progyny beat estimates in Q4 2025?: Revenue beat the consensus estimate of $307.4M by $11.0M. EPS beat the consensus estimate of $0.15 by $0.00.
How did Progyny's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 6.7% from $298.4M a year earlier and eps declined 64.3% from $0.42.
Where can I find Progyny's Q4 2025 SEC filings?: You can read the 8-K earnings release (0001551306-26-000012) and the 10-K periodic report (0001551306-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.